Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

ZIOPHARM Update

|Includes:ZIOPHARM Oncology, Inc. (ZIOP)
R & R finally picked up coverage today on ZIOP. $8 price target (within 12 months). The CEO (Dr. Lewis) is in UAE next week @ a medical meeting. Hopefully this will put a bit of wind in the sails.

Disclosure: Long ZIOP


Disclosure: LONG ZIOPHARM
Stocks: ZIOP